March 28, 2024 S&P 500 Soars 10% in Q1, Outstrips Bullish Forecasts
March 20, 2024 Fed Grapples With Rate Decision Amid Inflation Concerns
March 19, 2024 Bank of Japan Ends Era of Negative Rates
CashFlow Hunter On Pair Trading, 3M And Iris Energy
Apple: AI Strategy To Help Fight DOJ, Kickstart Growth
Nvidia Stock Priced As If It Will Deliver Us The Moon
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice
February 15, 2024 Vanskelig å Få Refinansiering: Why Was Your Refinancing Loan Denied?
Genprex (GNPX) Stock Forecast for 2024–2028. Sell or Buy?
Updated: March 29, 2024 (06:57)
Sector: HealthcareThe share price of Genprex, Inc. (GNPX) now
50/200 Day Moving Average: $5.75 / $15.81
This figure corresponds to the Average Price over the previous 50/200 days. For Genprex stocks, the 50-day moving average is the resistance level today.
For Genprex stocks, the 200-day moving average is the resistance level today.
Are you interested in Genprex, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Genprex stock price in 2024, 2025, 2026, 2027, 2028. How much will one Genprex share be worth in 2024 - 2028?
When should I take profit in Genprex stock? When should I record a loss on Genprex stock? What are analysts' forecasts for Genprex stock? What is the future of Genprex stock? We forecast Genprex stock performance using neural networks based on historical data on Genprex stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Genprex stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Genprex shares. This happens once a day.
Historical and forecast chart of Genprex stock
The chart below shows the historical price of Genprex stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Genprex stock price can be found in the table below.
Long-term forecasts by years.
Genprex, Inc. Is a clinical gene therapy company. The company is focused on developing oncology based on its new technology platform, including its initial candidate product, Oncoprex, immunogenotherapy or Oncoprex. Oncoprex consists of a tumor suppressor gene introduced into the cells of a patient, which has an immunomodulatory effect and is thus considered an immunogenic therapy. The gene is one of a number of genes licensed for therapeutic use by the University of Texas MD Anderson Cancer Center (MD Anderson). It is also developing preclinical gene therapy licensed by the University of Pittsburgh Commonwealth Higher Education System, which has the potential to treat type 1 and type 2 diabetes. He is developing his candidate product for use with targeted therapy and immunotherapy for non-small cell lung cancer (NSCLC).
Genprex daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Mar 31 | 4.66 | 4.54 | 4.79 | 5.48 |
Apr 01 | 4.74 | 4.68 | 4.89 | 4.49 |
Apr 02 | 4.70 | 4.58 | 4.75 | 3.62 |
Apr 03 | 4.74 | 4.61 | 4.83 | 4.72 |
Apr 04 | 4.73 | 4.66 | 4.79 | 2.92 |
Apr 05 | 4.92 | 4.79 | 4.97 | 3.71 |
Apr 06 | 4.82 | 4.71 | 4.87 | 3.43 |
Apr 07 | 4.76 | 4.64 | 4.86 | 4.85 |
Apr 08 | 4.63 | 4.49 | 4.69 | 4.44 |
Apr 09 | 4.43 | 4.34 | 4.53 | 4.26 |
Apr 10 | 4.41 | 4.32 | 4.55 | 5.18 |
Apr 11 | 4.50 | 4.45 | 4.61 | 3.43 |
Apr 12 | 4.51 | 4.40 | 4.63 | 5.06 |
Apr 13 | 4.56 | 4.48 | 4.63 | 3.33 |
Apr 14 | 4.74 | 4.69 | 4.83 | 2.82 |
Apr 15 | 4.88 | 4.80 | 4.93 | 2.54 |
Apr 16 | 5.03 | 4.97 | 5.12 | 3.05 |
Apr 17 | 4.99 | 4.90 | 5.12 | 4.46 |
Apr 18 | 4.86 | 4.72 | 4.95 | 4.78 |
Apr 19 | 4.83 | 4.71 | 4.99 | 5.87 |
Apr 20 | 4.91 | 4.77 | 4.96 | 4.03 |
Apr 21 | 4.70 | 4.56 | 4.84 | 5.98 |
Apr 22 | 4.81 | 4.69 | 4.90 | 4.45 |
Apr 23 | 4.74 | 4.57 | 4.85 | 6.06 |
Apr 24 | 4.74 | 4.68 | 4.85 | 3.44 |
Apr 25 | 4.81 | 4.65 | 4.90 | 5.42 |
Apr 26 | 4.67 | 4.55 | 4.71 | 3.66 |
Apr 27 | 4.67 | 4.57 | 4.81 | 5.32 |
Apr 28 | 4.72 | 4.62 | 4.83 | 4.53 |
Apr 29 | 4.76 | 4.60 | 4.81 | 4.67 |
Genprex Daily Price Targets
Genprex Stock Forecast 03-31-2024.
Forecast target price for 03-31-2024: $4.66.
Positive dynamics for Genprex shares will prevail with possible volatility of 5.196%.
Pessimistic target level: 4.54
Optimistic target level: 4.79
Genprex Stock Forecast 04-01-2024.
Forecast target price for 04-01-2024: $4.74.
Positive dynamics for Genprex shares will prevail with possible volatility of 4.296%.
Pessimistic target level: 4.68
Optimistic target level: 4.89
Genprex Stock Forecast 04-02-2024.
Forecast target price for 04-02-2024: $4.70.
Negative dynamics for Genprex shares will prevail with possible volatility of 3.490%.
Pessimistic target level: 4.58
Optimistic target level: 4.75
Genprex Stock Forecast 04-03-2024.
Forecast target price for 04-03-2024: $4.74.
Positive dynamics for Genprex shares will prevail with possible volatility of 4.512%.
Pessimistic target level: 4.61
Optimistic target level: 4.83
Genprex Stock Forecast 04-04-2024.
Forecast target price for 04-04-2024: $4.73.
Negative dynamics for Genprex shares will prevail with possible volatility of 2.841%.
Pessimistic target level: 4.66
Optimistic target level: 4.79
Genprex Stock Forecast 04-05-2024.
Forecast target price for 04-05-2024: $4.92.
Positive dynamics for Genprex shares will prevail with possible volatility of 3.575%.
Pessimistic target level: 4.79
Optimistic target level: 4.97
GNPX (GNPX) Monthly Stock Prediction for 2024
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Apr. | 4.82 | 4.24 | 5.31 | 20.06 |
May. | 4.76 | 4.59 | 5.25 | 12.48 |
Jun. | 4.73 | 4.17 | 5.03 | 17.14 |
Jul. | 4.31 | 3.86 | 4.60 | 16.04 |
Aug. | 4.41 | 3.86 | 4.86 | 20.61 |
Sep. | 4.49 | 4.24 | 4.91 | 13.60 |
Oct. | 5.05 | 4.77 | 5.43 | 12.18 |
Nov. | 5.02 | 4.80 | 5.18 | 7.44 |
Dec. | 5.26 | 5.04 | 5.67 | 11.13 |
Genprex forecast for this year
Genprex Stock Prediction for Apr 2024
An uptrend is forecast for this month with an optimal target price of $4.82046. Pessimistic: $4.24. Optimistic: $5.31
Genprex Stock Prediction for May 2024
An downtrend is forecast for this month with an optimal target price of $4.75876. Pessimistic: $4.59. Optimistic: $5.25
Genprex Stock Prediction for Jun 2024
An downtrend is forecast for this month with an optimal target price of $4.72831. Pessimistic: $4.17. Optimistic: $5.03
Genprex Stock Prediction for Jul 2024
An downtrend is forecast for this month with an optimal target price of $4.31221. Pessimistic: $3.86. Optimistic: $4.60
Genprex Stock Prediction for Aug 2024
An uptrend is forecast for this month with an optimal target price of $4.40881. Pessimistic: $3.86. Optimistic: $4.86
Genprex Stock Prediction for Sep 2024
An uptrend is forecast for this month with an optimal target price of $4.4864. Pessimistic: $4.24. Optimistic: $4.91
Genprex Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $5.04631. Pessimistic: $4.77. Optimistic: $5.43
Genprex Stock Prediction for Nov 2024
An downtrend is forecast for this month with an optimal target price of $5.02208. Pessimistic: $4.80. Optimistic: $5.18
Genprex Stock Prediction for Dec 2024
An uptrend is forecast for this month with an optimal target price of $5.25511. Pessimistic: $5.04. Optimistic: $5.67
Genprex (GNPX) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 5.65 | 5.19 | 6.05 | 14.20 |
Feb | 5.95 | 5.52 | 6.21 | 11.04 |
Mar | 5.15 | 4.63 | 5.48 | 15.49 |
Apr | 5.45 | 4.82 | 5.89 | 18.22 |
May | 5.84 | 5.55 | 6.33 | 12.39 |
Jun | 6.54 | 5.72 | 7.07 | 19.08 |
Jul | 6.19 | 5.66 | 6.98 | 18.89 |
Aug | 7.04 | 6.26 | 7.35 | 14.85 |
Sep | 6.66 | 6.02 | 7.13 | 15.55 |
Oct | 6.85 | 6.39 | 7.08 | 9.75 |
Nov | 5.86 | 5.27 | 6.51 | 19.02 |
Dec | 5.20 | 4.55 | 5.59 | 18.48 |
Genprex (GNPX) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 4.83 | 4.61 | 5.31 | 13.10 |
Feb | 4.96 | 4.54 | 5.16 | 12.00 |
Mar | 5.32 | 4.90 | 5.79 | 15.42 |
Apr | 5.33 | 4.67 | 5.85 | 20.26 |
May | 5.52 | 5.30 | 5.97 | 11.24 |
Jun | 5.28 | 4.73 | 5.52 | 14.40 |
Jul | 4.73 | 4.17 | 5.00 | 16.49 |
Aug | 4.17 | 3.73 | 4.51 | 17.33 |
Sep | 4.27 | 3.83 | 4.70 | 18.49 |
Oct | 4.44 | 3.88 | 4.78 | 18.75 |
Nov | 4.70 | 4.15 | 5.02 | 17.24 |
Dec | 5.25 | 4.80 | 5.64 | 14.75 |
Genprex (GNPX) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 5.74 | 5.46 | 6.46 | 15.48 |
Feb | 6.19 | 5.70 | 6.40 | 10.97 |
Mar | 6.46 | 5.87 | 7.29 | 19.43 |
Apr | 7.00 | 6.70 | 7.76 | 13.71 |
May | 7.60 | 7.26 | 8.37 | 13.35 |
Jun | 8.35 | 7.95 | 8.79 | 9.57 |
Jul | 7.04 | 6.75 | 7.66 | 11.91 |
Aug | 7.04 | 6.45 | 7.94 | 18.72 |
Sep | 7.52 | 7.02 | 8.33 | 15.75 |
Oct | 7.85 | 7.05 | 8.15 | 13.56 |
Nov | 8.49 | 7.89 | 9.44 | 16.40 |
Dec | 8.87 | 8.29 | 9.96 | 16.81 |
Genprex (GNPX) Monthly Stock Prediction for 2028
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 10.03 | 9.54 | 10.95 | 12.90 |
Feb | 10.03 | 9.38 | 10.95 | 14.37 |
Mar | 9.52 | 8.82 | 10.05 | 12.27 |
Apr | 11.01 | 10.45 | 12.25 | 14.68 |
May | 12.00 | 10.96 | 12.63 | 13.22 |
Jun | 11.46 | 10.89 | 12.78 | 14.78 |
Jul | 10.01 | 8.80 | 10.57 | 16.82 |
Aug | 9.63 | 8.97 | 10.85 | 17.33 |
Sep | 9.09 | 7.93 | 9.95 | 20.32 |
Oct | 7.75 | 7.01 | 8.01 | 12.54 |
Nov | 7.86 | 7.55 | 8.87 | 14.89 |
Dec | 7.60 | 6.72 | 8.10 | 16.97 |
Genprex information and performance
100 CONGRESS AVENUE, SUITE 2000, AUSTIN, TX, US
Market capitalization of the Genprex, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of GNPX shares in the company outstanding by the market price of one share.
EBITDA of Genprex is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.